Research Analysts Offer Predictions for SBC Q1 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Zacks Small Cap issued their Q1 2025 EPS estimates for SBC Medical Group in a research note issued to investors on Wednesday, April 2nd. Zacks Small Cap analyst M. Marin forecasts that the company will post earnings per share of $0.06 for the quarter. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Zacks Small Cap also issued estimates for SBC Medical Group’s Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.06 EPS, Q3 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.07 EPS, FY2025 earnings at $0.26 EPS and FY2025 earnings at $0.26 EPS.

SBC Medical Group (NASDAQ:SBC) last announced its earnings results on Friday, March 28th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $57.90 million for the quarter, compared to analysts’ expectations of $56.34 million.

SBC Medical Group Stock Performance

Shares of SBC stock opened at $3.29 on Friday. SBC Medical Group has a fifty-two week low of $2.62 and a fifty-two week high of $12.50. The company has a 50 day simple moving average of $4.22. The company has a quick ratio of 2.76, a current ratio of 2.79 and a debt-to-equity ratio of 0.06.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.